UniProt ID | AIFM1_MOUSE | |
---|---|---|
UniProt AC | Q9Z0X1 | |
Protein Name | Apoptosis-inducing factor 1, mitochondrial | |
Gene Name | Aifm1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 612 | |
Subcellular Localization | Mitochondrion intermembrane space . Mitochondrion inner membrane. Cytoplasm. Cytoplasm, perinuclear region. Nucleus . Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of | |
Protein Description | Functions both as NADH oxidoreductase and as regulator of apoptosis. In response to apoptotic stimuli, it is released from the mitochondrion intermembrane space into the cytosol and to the nucleus, where it functions as a proapoptotic factor in a caspase-independent pathway. In contrast, functions as an antiapoptotic factor in normal mitochondria via its NADH oxidoreductase activity. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e. caspase-independent fragmentation of chromosomal DNA. Interacts with EIF3G,and thereby inhibits the EIF3 machinery and protein synthesis,and activates casapse-7 to amplify apoptosis. Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Binds to DNA in a sequence-independent manner (By similarity).. | |
Protein Sequence | MFRCGGLAGAFKQKLVPLVRTVYVQRPKQRNRLPGNLFQQWRVPLELQMARQMASSGSSGGKMDNSVLVLIVGLSTIGAGAYAYKTIKEDQKRYNERVMGLGLSPEEKQRRAIASATEGGSVPQIRAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLQFRQWNGKERSIYFQPPSFYVSAQDLPNIENGGVAVLTGKKVVHLDVRGNMVKLNDGSQITFEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRALEKISREVKSITVIGGGFLGSELACALGRKSQASGIEVIQLFPEKGNMGKILPQYLSNWTMEKVKREGVKVMPNAIVQSVGVSGGRLLIKLKDGRKVETDHIVTAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYEAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSAPAVPQVPVEGEDYGKGVIFYLRDKVVVGIVLWNVFNRMPIARKIIKDGEQHEDLNEVAKLFNIHED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
104 | Phosphorylation | RVMGLGLSPEEKQRR HHCCCCCCHHHHHHH | 28.59 | 29514104 | |
108 | Ubiquitination | LGLSPEEKQRRAIAS CCCCHHHHHHHHHHH | 47.66 | - | |
108 | Acetylation | LGLSPEEKQRRAIAS CCCCHHHHHHHHHHH | 47.66 | 23806337 | |
108 | Succinylation | LGLSPEEKQRRAIAS CCCCHHHHHHHHHHH | 47.66 | 23806337 | |
108 | Malonylation | LGLSPEEKQRRAIAS CCCCHHHHHHHHHHH | 47.66 | 26320211 | |
108 | Succinylation | LGLSPEEKQRRAIAS CCCCHHHHHHHHHHH | 47.66 | - | |
115 | Phosphorylation | KQRRAIASATEGGSV HHHHHHHHHCCCCCC | 29.61 | 25521595 | |
117 | Phosphorylation | RRAIASATEGGSVPQ HHHHHHHCCCCCCCC | 32.44 | 29472430 | |
121 | Phosphorylation | ASATEGGSVPQIRAP HHHCCCCCCCCCCCC | 41.29 | 22324799 | |
129 | Phosphorylation | VPQIRAPSHVPFLLI CCCCCCCCCCCEEEE | 35.81 | 23140645 | |
188 | Ubiquitination | SDDPNVTKTLQFRQW CCCCCCCEEEEEEEC | 42.85 | - | |
198 | Succinylation | QFRQWNGKERSIYFQ EEEECCCCCCEEEEC | 46.90 | 23954790 | |
230 | Succinylation | GVAVLTGKKVVHLDV EEEEEECCEEEEEEC | 36.84 | 23954790 | |
230 | Acetylation | GVAVLTGKKVVHLDV EEEEEECCEEEEEEC | 36.84 | 2374687 | |
231 | Acetylation | VAVLTGKKVVHLDVR EEEEECCEEEEEECC | 51.32 | 2395425 | |
243 | Acetylation | DVRGNMVKLNDGSQI ECCCCEEECCCCCEE | 30.70 | 23864654 | |
243 | Malonylation | DVRGNMVKLNDGSQI ECCCCEEECCCCCEE | 30.70 | 26320211 | |
248 | Phosphorylation | MVKLNDGSQITFEKC EEECCCCCEEEEEEE | 22.67 | 25159016 | |
255 | S-nitrosylation | SQITFEKCLIATGGT CEEEEEEEEEECCCC | 2.33 | 22178444 | |
255 | S-nitrosocysteine | SQITFEKCLIATGGT CEEEEEEEEEECCCC | 2.33 | - | |
265 | Phosphorylation | ATGGTPRSLSAIDRA ECCCCCCCHHHHHHC | 28.07 | 26745281 | |
267 | Phosphorylation | GGTPRSLSAIDRAGA CCCCCCHHHHHHCCC | 25.15 | 22942356 | |
277 | Acetylation | DRAGAEVKSRTTLFR HHCCCCHHCCHHHHH | 26.23 | 23864654 | |
278 | Phosphorylation | RAGAEVKSRTTLFRK HCCCCHHCCHHHHHH | 39.78 | 26060331 | |
294 | Malonylation | GDFRALEKISREVKS CCHHHHHHHCHHCCE | 47.00 | 26073543 | |
301 | Phosphorylation | KISREVKSITVIGGG HHCHHCCEEEEECCC | 28.77 | 25777480 | |
303 | Phosphorylation | SREVKSITVIGGGFL CHHCCEEEEECCCHH | 17.11 | 25777480 | |
312 | Phosphorylation | IGGGFLGSELACALG ECCCHHHHHHHHHHC | 31.42 | 25777480 | |
316 | S-nitrosylation | FLGSELACALGRKSQ HHHHHHHHHHCCCHH | 5.13 | 21278135 | |
316 | Glutathionylation | FLGSELACALGRKSQ HHHHHHHHHHCCCHH | 5.13 | 24333276 | |
316 | S-nitrosocysteine | FLGSELACALGRKSQ HHHHHHHHHHCCCHH | 5.13 | - | |
336 | Malonylation | VIQLFPEKGNMGKIL EEECCCCCCCHHHCH | 56.68 | 26320211 | |
336 | Acetylation | VIQLFPEKGNMGKIL EEECCCCCCCHHHCH | 56.68 | 23864654 | |
341 | Acetylation | PEKGNMGKILPQYLS CCCCCHHHCHHHHHH | 30.24 | 23864654 | |
361 | Acetylation | KVKREGVKVMPNAIV HHHHCCCEECCCEEE | 43.61 | 23864654 | |
370 | Phosphorylation | MPNAIVQSVGVSGGR CCCEEEEEECEECCE | 15.22 | 29472430 | |
374 | Phosphorylation | IVQSVGVSGGRLLIK EEEEECEECCEEEEE | 29.60 | 29472430 | |
381 | Acetylation | SGGRLLIKLKDGRKV ECCEEEEEECCCCEE | 49.83 | 23864654 | |
387 | Acetylation | IKLKDGRKVETDHIV EEECCCCEEECCEEE | 50.37 | 23576753 | |
387 | Malonylation | IKLKDGRKVETDHIV EEECCCCEEECCEEE | 50.37 | 26320211 | |
407 | Acetylation | EPNVELAKTGGLEID CCCCEEHHHCCEEEC | 61.40 | 23864654 | |
408 | Phosphorylation | PNVELAKTGGLEIDS CCCEEHHHCCEEECC | 30.76 | 29472430 | |
415 | Phosphorylation | TGGLEIDSDFGGFRV HCCEEECCCCCCEEE | 40.27 | 19060867 | |
440 | S-nitrosocysteine | WVAGDAACFYDIKLG EEEECCEEEEECEEC | 3.30 | - | |
440 | S-nitrosylation | WVAGDAACFYDIKLG EEEECCEEEEECEEC | 3.30 | 21278135 | |
445 | Acetylation | AACFYDIKLGRRRVE CEEEEECEECCCCCC | 41.83 | 23201123 | |
499 | Phosphorylation | EAIGLVDSSLPTVGV HHHHCCCCCCCCCEE | 26.71 | - | |
500 | Phosphorylation | AIGLVDSSLPTVGVF HHHCCCCCCCCCEEE | 33.63 | - | |
503 | Phosphorylation | LVDSSLPTVGVFAKA CCCCCCCCCEEEEEE | 34.87 | - | |
517 | Malonylation | ATAQDNPKSATEQSG EECCCCCCCHHHCCC | 60.00 | 26320211 | |
517 | Ubiquitination | ATAQDNPKSATEQSG EECCCCCCCHHHCCC | 60.00 | - | |
518 | Phosphorylation | TAQDNPKSATEQSGT ECCCCCCCHHHCCCC | 41.50 | 25619855 | |
520 | Phosphorylation | QDNPKSATEQSGTGI CCCCCCHHHCCCCCC | 41.47 | 25619855 | |
523 | Phosphorylation | PKSATEQSGTGIRSE CCCHHHCCCCCCCCC | 31.90 | 23140645 | |
529 | Phosphorylation | QSGTGIRSESETESE CCCCCCCCCCCCCCC | 43.48 | - | |
533 | Phosphorylation | GIRSESETESEASEI CCCCCCCCCCCCCCC | 54.83 | - | |
589 | Malonylation | NRMPIARKIIKDGEQ CCCHHHHHHHCCCCC | 39.50 | 26320211 | |
589 | Acetylation | NRMPIARKIIKDGEQ CCCHHHHHHHCCCCC | 39.50 | 23576753 | |
592 | Malonylation | PIARKIIKDGEQHED HHHHHHHCCCCCCCC | 64.25 | 26320211 | |
592 | Acetylation | PIARKIIKDGEQHED HHHHHHHCCCCCCCC | 64.25 | 23576753 | |
592 | Succinylation | PIARKIIKDGEQHED HHHHHHHCCCCCCCC | 64.25 | 23954790 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AIFM1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
254 | K | ubiquitylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AIFM1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BAG6_MOUSE | Bag6 | physical | 18056262 | |
KAD2_HUMAN | AK2 | physical | 26496610 | |
CLUS_HUMAN | CLU | physical | 26496610 | |
CX6B1_HUMAN | COX6B1 | physical | 26496610 | |
HMGB1_HUMAN | HMGB1 | physical | 26496610 | |
PHB_HUMAN | PHB | physical | 26496610 | |
VDAC1_HUMAN | VDAC1 | physical | 26496610 | |
NUDC_HUMAN | NUDC | physical | 26496610 | |
MIC60_HUMAN | IMMT | physical | 26496610 | |
PHB2_HUMAN | PHB2 | physical | 26496610 | |
STML2_HUMAN | STOML2 | physical | 26496610 | |
MIC19_HUMAN | CHCHD3 | physical | 26496610 | |
MIC25_HUMAN | CHCHD6 | physical | 26496610 | |
MIA40_HUMAN | CHCHD4 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-592, AND MASS SPECTROMETRY. |